Health news
The Food and Drug Administration (FDA) has granted Fast Track designation to CNP-104 for the treatment of primary biliary cholangitis (PBC). Primary biliary cholangitis (PBC) is a rare autoimmune liver disease characterized by immune-mediated destruction…
The Food and Drug Administration has approved Livmarli (maralixibat) oral solution for the treatment of cholestatic pruritus in patients with Alagille syndrome 1 year of age and older. Livmarli is a reversible inhibitor of the…
© 2005-2021 Top-Meds - All rights reserved. Our website services, content, and products are for informational purposes only. Top-Meds does not provide medical advice, diagnosis, or treatment. | Medical News 2021